Your browser doesn't support javascript.
loading
Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation.
Arora, Kavisha; Yarlagadda, Sunitha; Zhang, Weiqiang; Moon, ChangSuk; Bouquet, Erin; Srinivasan, Saumini; Li, Chunying; Stokes, Dennis C; Naren, Anjaparavanda P.
Afiliação
  • Arora K; Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;
  • Yarlagadda S; Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;
  • Zhang W; Department of Physiology, University of Tennessee Health Science Center and University of Tennessee CF Care and Research Center at Le Bonheur Children's Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center and University of Tennessee CF Care and Resea
  • Moon C; Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;
  • Bouquet E; Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;
  • Srinivasan S; Department of Physiology, University of Tennessee Health Science Center and University of Tennessee CF Care and Research Center at Le Bonheur Children's Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center and University of Tennessee CF Care and Resea
  • Li C; School of Medicine, Wayne State University, Detroit, Michigan.
  • Stokes DC; Department of Physiology, University of Tennessee Health Science Center and University of Tennessee CF Care and Research Center at Le Bonheur Children's Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center and University of Tennessee CF Care and Resea
  • Naren AP; Division of Pulmonary Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; anaren@cchmc.org.
Am J Physiol Lung Cell Mol Physiol ; 311(2): L364-74, 2016 Aug 01.
Article em En | MEDLINE | ID: mdl-27261451
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulador de Condutância Transmembrana em Fibrose Cística / Genisteína / Fibrose Cística / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Child, preschool / Humans / Male Idioma: En Revista: Am J Physiol Lung Cell Mol Physiol Assunto da revista: BIOLOGIA MOLECULAR / FISIOLOGIA Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulador de Condutância Transmembrana em Fibrose Cística / Genisteína / Fibrose Cística / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Child, preschool / Humans / Male Idioma: En Revista: Am J Physiol Lung Cell Mol Physiol Assunto da revista: BIOLOGIA MOLECULAR / FISIOLOGIA Ano de publicação: 2016 Tipo de documento: Article